Stroke, Vol 25, 877-885, Copyright © 1994 by American Heart Association
T Nishikawa, JR Kirsch, RC Koehler, M Miyabe and RJ Traystman
BACKGROUND AND PURPOSE: We tested the hypothesis that inhibiting nitric
oxide production either before or during transient focal ischemia affects
early postischemic brain injury. METHODS: Halothane- anesthetized cats
underwent 1 hour of left middle cerebral artery occlusion plus 3 hours of
reperfusion. Pretreatment groups received either intravenous N
omega-nitro-L-arginine methyl ester (L-NAME; 10 mg/kg, n = 10) or an equal
volume of diluent (10 mL saline, n = 10) over 30 minutes before ischemia.
Posttreatment groups received intravenous L-NAME (10 mg/kg) over 30 minutes
from 45 minutes of ischemia to 15 minutes of reperfusion (n = 10) or
intravenous L-NAME (10 mg/kg) plus L-arginine (200 mg/kg) over the same
period followed by continuous L-arginine infusion (200 mg/kg per hour) for
the remainder of reperfusion (n = 10). RESULTS: Microsphere-determined
blood flow to ipsilateral caudate nucleus and inferior temporal cortex
decreased to the same extent during ischemia and recovered to the same
extent during reperfusion in the four groups.
Triphenyltetrazolium-determined injury volume of ipsilateral caudate
nucleus in cats treated with L-NAME before or during ischemia (42 +/- 7%
and 42 +/- 3% of caudate nucleus, respectively; mean +/- SE) was less (P
< .05) compared with that in cats pretreated with saline (72 +/- 5%) or
cats treated with L-NAME plus L-arginine (68 +/- 5%). Ipsilateral cerebral
hemispheric injury volume was similar among the four groups (23 +/- 5%, 13
+/- 3%, 18 +/- 5%, and 29 +/- 5% of hemisphere in groups treated with
L-NAME before ischemia and during ischemia, the saline-treated group, and
the group treated with L-NAME plus L-arginine, respectively). CONCLUSIONS:
Inhibition of nitric oxide synthase decreases caudate injury volume from
transient focal cerebral ischemia in cats. The beneficial effect is
reversed by L-arginine and is not caused by favorable redistribution of
blood flow during ischemia and reperfusion. Because L-NAME was efficacious
when administered at reperfusion, nitric oxide generated during reperfusion
appears to contribute to caudate injury.
ARTICLES
Nitric oxide synthase inhibition reduces caudate injury following transient focal ischemia in cats
Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions, Baltimore, Md 21287-4963.
This article has been cited by other articles:
![]() |
H. SCHUTTE, K. MAYER, H. BURGER, M. WITZENRATH, T. GESSLER, W. SEEGER, and F. GRIMMINGER Endogenous Nitric Oxide Synthesis and Vascular Leakage in Ischemic-Reperfused Rabbit Lungs Am. J. Respir. Crit. Care Med., August 1, 2001; 164(3): 412 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Oka, Y. Itoh, and Y. Ukai Preferential Inhibition by a Novel Na+/Ca2+ Channel Blocker NS-7 of Severe to Mild Hypoxic Injury in Rat Cerebrocortical Slices: A Possible Involvement of a Highly Voltage-Dependent Blockade of Ca2+ Channel J. Pharmacol. Exp. Ther., May 1, 2000; 293(2): 522 - 529. [Abstract] [Full Text] |
||||
![]() |
J. R. Kirsch, A. Bhardwaj, L. J. Martin, D. F. Hanley, and R. J. Traystman Neither L-Arginine nor L-NAME Affects Neurological Outcome After Global Ischemia in Cats Stroke, November 1, 1997; 28(11): 2259 - 2265. [Abstract] [Full Text] |
||||
![]() |
G. T. Gobbel, T. Y.-Y. Chan, and P. H. Chan Nitric Oxide- and Superoxide-Mediated Toxicity in Cerebral Endothelial Cells J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1600 - 1607. [Abstract] [Full Text] |
||||
![]() |
M. Izuta, N. Clavier, J. R. Kirsch, and R. J. Traystman Cerebral Blood Flow During Inhibition of Brain Nitric Oxide Synthase Activity in Normal, Hypertensive, and Stroke-Prone Rats Stroke, June 1, 1995; 26(6): 1079 - 1085. [Abstract] [Full Text] |
||||
![]() |
R. J. Traystman, L. E. Moore, M. A. Helfaer, S. Davis, K. Banasiak, M. Williams, and P. D. Hurn Nitro-L-Arginine Analogues : Dose- and Time-Related Nitric Oxide Synthase Inhibition in Brain Stroke, May 1, 1995; 26(5): 864 - 869. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |